You can buy or sell SAVA and other stocks, options, ETFs, and crypto commission-free!
Cassava Sciences, Inc. engages in the development of novel drugs. It focuses on developing product candidates intended for the treatment of Alzheimer's disease, including PTI-125 and PTI-125Dx. Read More The company was founded by Remi Barbier and Barry M. Sherman in May 1998 and is headquartered in Austin, TX.
52 Week High
52 Week Low
Expected Nov 4, Pre-Market